Corporate Board Profile
Tech Score: 9/100
1 mention(s) identify CHARLES R. KUMMETH as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Orthofix Medical Inc. | 2024-04-29 | Mr. Kummeth received a BS in Electrical Engineering from the University of North Dakota, and MS in Computer Science from the University of St. Thomas and an MBS from the Carlson School of Business at the University of Minnesota. He is currently a Senior Advisor at Bio-Techne Corporation, a leading developer and manufacturer of high-quality purified proteins, antibodies, immunoassays, and instruments for biomedical researchers and clinical research laboratories. | Has a Master of Science in Computer Science and extensive experience in technology and life sciences companies, indicating software-related technical skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2013-09-20 | Charles R. Kummeth has been President and Chief Executive Officer of the Company since April 1, 2013. Prior to joining the Company, he served as President of Mass Spectrometry and Chromatography at Thermo Fisher Scientific Inc. from September 2011. He was President of that company 27s Laboratory Consumables Division from 2009 to September 2011. Prior to joining Thermo Fisher, Mr. Kummeth served in various roles at 3M Corporation, most recently as the Vice President of the company 27s Medical Division from 2006 to 2008. Among other attributes, skills and qualifications, the Board believes that Mr. Kummeth is qualified to serve as a Director of the Company because of his experience leading the growth of biotechnology companies. In addition, the Board believes that having the Chief Executive officer serve as a member of the Board promotes strategy development and implementation and facilitates the flow of information between the Board and management. |
| 2014-09-19 | Charles R. Kummeth has been President, Chief Executive Officer, and member of the Board of the Company since April 1, 2013. |
| 2015-09-18 | Charles R. Kummeth, age 55, has been President, Chief Executive Officer, and member of the Board of the Company since April 1, 2013. ... The Board believes that Mr. Kummeth is qualified to serve as a Director of the Company because of his experience leading the growth of biotechnology companies. ... The Board believes that having the Chief Executive Officer serve as a member of the Board promotes strategy development and implementation and facilitates the flow of information between the Board and management. |
| 2016-09-13 | Charles R. Kummeth, age 56, has been President, Chief Executive Officer, and member of the Board of the Company since April 1, 2013. ... Directors who are not employees of the Company do not receive any compensation for service on the Board. ... 2016 Summary Compensation Table shows Charles R. Kummeth total compensation $7,468,114. |
| 2017-09-12 | Charles R. Kummeth has been President, Chief Executive Officer, and member of the Board of the Company since April 1, 2013... Mr. Kummeth is not independent based on his service as the Company’s CEO and President. |
| 2018-09-11 | Charles R. Kummeth has been President, CEO, and Board member since 2013... No committee memberships listed for Mr. Kummeth. Executive Compensation section details CEO compensation. |
| 2019-09-09 | Charles R. Kummeth Age: 59 Director Since: 2013 Other Public Directorships: Gentherm, Inc. Charles R. Kummeth has been President, Chief Executive Officer, and member of the Board of the Company since April 1, 2013. Prior to joining the Company, he served as President of Mass Spectrometry and Chromatography at Thermo Fisher Scientific Inc. from September 2011. He was President of that company’s Laboratory Consumables Division from 2009 to September 2011. Prior to joining Thermo Fisher, Mr. Kummeth served in various roles at 3M Corporation, most recently as the Vice President of the company’s Medical Division from 2006 to 2008. Mr. Kummeth also serves on the board of one other public company, Gentherm, Inc., developer of thermal management technologies. As the only member of Company management to serve on the Board, Mr. Kummeth provides the board with key insight into the day-to-day operations of the Company and its primary challenges. Mr. Kummeth’s service on the Board also promotes strategy development and implementation and facilitates the flow of information between the Board and management. Mr. Kummeth further offers extensive significant executive management experience and expertise leading the growth of biotechnology companies. |
| 2020-09-15 | Charles R. Kummeth Age: 60 President and CEO, Bio-Techne Corporation Director Since: 2013 CEO and only management member on the Board Total annual compensation for FY 2020: $11,484,782 |
| 2022-09-14 | Charles R. Kummeth Age: 62 Director since: 2013 President and CEO ...Director Compensation Charles R. Kummeth Total ($): 15,370,549 |
| 2023-09-13 | Charles R. Kummeth Age: 63 Director since: 2013 President and CEO, Bio-Techne Corporation Compensation Paid to the Non-Employee Directors Charles R. Kummeth $30,584,644 |
| Filing Date | Source Excerpt |
|---|---|
| 2024-04-29 | Mr. Kummeth received a BS in Electrical Engineering from the University of North Dakota, and MS in Computer Science from the University of St. Thomas and an MBS from the Carlson School of Business at the University of Minnesota. He is currently a Senior Advisor at Bio-Techne Corporation, a leading developer and manufacturer of high-quality purified proteins, antibodies, immunoassays, and instruments for biomedical researchers and clinical research laboratories. |
Data sourced from SEC filings. Last updated: 2025-12-06